The Chinese facility that supplies the active ingredient of the widely used blood thinner heparin was never inspected by the Food and Drug Administration because the agency confused its name with another just like it, agency officials said yesterday. More than 350 adverse reactions to the drug have been reported to the FDA since the end of 2007. Four patients who took the drug died. |
Read the rest of the story HERE:
At www.washingtonpost.com
Sheila Samples is an Oklahoma writer and a former civilian US Army Public Information Officer. She is a Managing Editor for OpEd News, and a regular contributor for a variety of Internet sites.